 granulocyte-macrophag colony-stimul factor neutropenia combin interferon alfa zidovudin treatment immun defici syndrome-associ kaposi sarcoma combin use zidovudin zdv interferon ifn antiretrovir antitumor potenti benefit treatment immun defici syndrom aid kaposi sarcoma KS clinic use combin myelotox agent result phase i/ii studi granulocyte-macrophag colony-stimul factor gm-csf KS patient neutropen zdv mg/d ifn u/d nineteen patient absolut neutrophil count anc cell cubic millimet gm-csf all prompt increas anc patient gm-csf/zdv/ifn improv end studi anc zdv/ifn group rate tumor respons end studi cell count improv hematolog variabl use gm-csf increas toxic particular chang serum human immunodefici viru hiv antigen tumor respons assess patient overal high-risk characterist respond patient gm-csf alter zdv/ifn dose level further studi gm-csf altern modif zdv/ifn combin therapi aid patient